PLUS THERAPEUTICS, INC. — Director's Dealing 2012

Mar 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2012-03-14

Reporting Person: Saad Mark E (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-14	Common Stock	P	9400	$2.55	Acquired	151900	Direct
2012-03-14	Common Stock	P	600	$2.54	Acquired	152500	Direct